Results 271 to 280 of about 413,028 (398)

Provider‐Led Interventions to Reduce Congenital Cytomegalovirus

open access: yesJournal of Midwifery &Women's Health, EarlyView.
Introduction Cytomegalovirus (CMV) infection immediately before or during pregnancy can infect a fetus transplacentally, causing congenital CMV (cCMV). cCMV can cause miscarriage, stillbirth, growth restriction, neurodevelopmental delay, hearing, and vision impairment.
Erin Trisko   +3 more
wiley   +1 more source

Mycoplasma‐Induced Rash and Mucositis: Ocular Manifestations, Treatment and Outcomes in a Paediatric Population

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background There has been an increase in Mycoplasma pneumoniae infections. This can present with extra‐pulmonary manifestations including mycoplasma‐induced rash and mucositis (MIRM). This paper aims to describe the ocular features in MIRM at a paediatric tertiary referral hospital in Queensland, Australia, and review the treatment and ...
Daniel Cool   +4 more
wiley   +1 more source

Painful Realities: Navigating the Complexities of Head and Neck Cancer Pain

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Head and neck cancer (HNC) and its treatments can cause significant pain, which can profoundly impact patients' quality of life and treatment outcomes. Understanding the full scope of HNC pain is essential for effective management and improved patient care.
Hayden F. Byrd, Zachary A. Kohutek
wiley   +1 more source

Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms. [PDF]

open access: yesSci Rep
Quinn CH   +10 more
europepmc   +1 more source

A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background Alopecia areata (AA) is an autoimmune disease characterized by hair loss that can negatively impact quality of life. AA has a significant pediatric prevalence; however, no systemic treatments are approved for AA in patients aged < 12 years. Ritlecitinib, a JAK3/TEC family kinase inhibitor, is approved to treat adults and adolescents
Mercedes E. Gonzalez   +7 more
wiley   +1 more source

Case Report: Donor-derived herpes simplex virus type 1 hepatitis in a kidney transplant recipient with fatal outcome. [PDF]

open access: yesFront Transplant
Lindahl JP   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy